Xenon Pharmaceuticals
XENE
XENE
202 hedge funds and large institutions have $2.95B invested in Xenon Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 76 increasing their positions, 62 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
0.56% more ownership
Funds ownership: 98.28% → 98.84% (+0.56%)
5% less funds holding
Funds holding: 213 → 202 (-11)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
Holders
202
Holding in Top 10
9
Calls
$4.78M
Puts
$1.13M
Top Buyers
| 1 | +$59.3M | |
| 2 | +$35.6M | |
| 3 | +$15M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$11.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.62M |
Top Sellers
| 1 | -$79.7M | |
| 2 | -$25.6M | |
| 3 | -$14.9M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$14.6M |
| 5 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$9.77M |